BC
NVAX icon

Bridgefront Capital’s Novavax NVAX Stock Holding History

Bridgefront Capital’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$708K Buy
+86,918
New +$788K 0.18% 195
2025
Q4 		– Sell
-16,788
Closed -$146K – 699
2025
Q3 		$146K Sell
16,788
-20,069
-54% -$156K 0.04% 544
2025
Q2 		$232K Buy
+36,857
New +$244K 0.06% 509
2023
Q1 		– Sell
-10,573
Closed -$109K – 533
2022
Q4 		$109K Buy
+10,573
New +$187K 0.08% 333
2022
Q1 		– Sell
-1,403
Closed -$201K – 380
2021
Q4 		$201K Buy
+1,403
New +$241K 0.2% 246
2021
Q3 		– Sell
-1,412
Closed -$300K – 578
2021
Q2 		$300K Buy
+1,412
New +$259K 0.11% 343

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bridgefront Capital's NVAX Position: Q1 2026 in Review

Bridgefront Capital opened a new position in Novavax (NVAX) in Q1 2026: 86,918 shares worth $708K. The stake represents 0.18% of the portfolio and ranks #195 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in NVAX as recently as Q3 2025.

Bridgefront Capital first reported a position in NVAX in Q2 2021 and has held it in 6 quarters since. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Bridgefront Capital held 86,918 shares of Novavax worth $708K as of Q1 2026.
  • Novavax was a new Bridgefront Capital position in Q1 2026.
  • Novavax made up 0.18% of Bridgefront Capital's portfolio in Q1 2026, its #195 holding.
  • Bridgefront Capital first reported a position in Novavax in Q2 2021 and has held it in 6 quarters since.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.